Abstract: An apparatus configured to establish a first radio link for short range communications using a first protocol and a second radio link for short range communications using a second protocol, wherein the first and second radio links share an antenna, process traffic load information for the first radio link, the information being dependent on configuration parameters for the first radio link, determine, based on the information, time domain resources available for second data traffic on the second radio link, based on the time domain resources available for the second data traffic on the second radio link, determine a fragmentation size for packets sent on the second radio link and generate transmissions to exchange the second data traffic in the time domain resources available for the second data traffic on the second radio link in fragmented packets according to the determined fragmentation size.

Abstract: A method is provided. The method includes attaching a user device to a wireless network via a router of a first communications protocol. The method includes determining, based on information about a second session using a second communications protocol, a first time window and a second time window. The method includes determining to perform a first session using the first communications protocol in the first time window. The method includes performing a first arbitration between the first session and the second session. The method includes determining, based on the first arbitration, that the first session has a priority over the second session in the second time window. The method includes performing a second arbitration between the first session and a third session using a third communications protocol. The method includes determining, based on the second arbitration, whether to perform the first session in the second time window.

Abstract: Methods and apparatus for monitoring and controlling access to coexisting first and second networks within a venue. In one embodiment, the first network is a managed content delivery network that includes one or more wireless access points (APs) in data communication with a backend controller which communicates with a dedicated background scanner. The background scanner scans for coexisting networks within the venue, and reports this to the controller. In one variant, the controller dynamically adjusts transmit characteristics of the AP(s) to manage interference between the coexisting networks. In another variant, the controller causes the energy detect threshold of a client device to be lowered so that the device may detect WLAN signals in a scenario where a coexisting RAT (for example, LTE-U or LTE-LAA) occupies the same channel and/or frequency.

Abstract: Disclosed herein are compositions and pharmaceutical formulations that comprise a binding moiety conjugated to a polynucleic acid molecule and a polymer. Also described herein include methods for treating a cancer which utilize a composition or a pharmaceutical formulation comprising a binding moiety conjugated to a polynucleic acid molecule and a polymer.

Abstract: Methods and devices are disclosed for supporting emergency service calls using dynamic service set identifier (SSID) deployment in a wireless communication network. An access point may receive an emergency service call request from a user device. The access point may also send a message with information about the received emergency service call request to a wireless network manager, and determine whether determining whether to serve the emergency service call request based on a response message received from the wireless network manager. In response to determining to serve the emergency service call request, the access point may create a new service set identifier (SSID) with emergency service call capability.

Abstract: The present disclosure relates to an apparatus for generating light pulses, comprising a laser device configured to output the light pulses and a pulse driver configured to supply electrical pulses to the laser device to drive the laser device. Furthermore, the pulse driver is configured to supply the electrical pulses with amplitudes/intensities obeying a pre-determined probability distribution to the laser device such that quadrature values of the light pulses obey another pre-determined probability distribution.

Abstract: Disclosed herein are antibody oligonucleotide conjugates and pharmaceutical compositions that induce an alteration in an incorrectly spliced dystrophin mRNA transcript to induce exon 44 skipping. Also described herein include methods for treating muscle dystrophy including Duchenne muscular dystrophy that comprises administering antibody oligonucleotide conjugates or a pharmaceutical composition that induces alteration in an incorrectly spliced dystrophin mRNA transcript to induce exon 44 skipping.

Abstract: Techniques for improving the execution of database queries in a multi-processor system or distributed processing system environment are provided. In a database system including multiple parsing engines (PEs) for parsing database queries, or requests, received by the system and generating execution plans for the requests, execution plans generated for requests can be saved in a global request cache accessible to each of the parsing engines. Requests which have been parsed and cached by a PE can be retrieved for use by other PEs, thereby avoiding unnecessarily parsing the same database request in multiple PEs. The global request cache may be a distributed cache consisting of request caches local to each parsing engine, with execution plans allocated to the local request caches using hashing techniques applied to the database requests associated with the execution plans.

Abstract: Disclosed herein are molecules and pharmaceutical compositions that induce an insertion, deletion, duplication, or alteration in an incorrectly spliced mRNA transcript to induce exon skipping or exon inclusion. Also described herein include methods for treating a disease or disorder that comprises a molecule or a pharmaceutical composition that induces an insertion, deletion, duplication, or alteration in an incorrectly spliced mRNA transcript to induce exon skipping or exon inclusion.

Abstract: Methods and apparatus for monitoring and controlling access to coexisting first and second networks within a venue. In one embodiment, the first network is a managed content delivery network that includes one or more wireless access points (APs) in data communication with a backend controller which communicates with a dedicated background scanner. The background scanner scans for coexisting networks within the venue, and reports this to the controller. In one variant, the controller dynamically adjusts transmit characteristics of the AP(s) to manage interference between the coexisting networks. In another variant, the controller causes the energy detect threshold of a client device to be lowered so that the device may detect WLAN signals in a scenario where a coexisting RAT (for example, LTE-U or LTE-LAA) occupies the same channel and/or frequency.

Abstract: In one example, a non-transitory computer-readable storage medium with program instructions for determining anomalies in machine learning models and impact on business output data thereof is disclosed. The method accesses machine learning model variables for a machine learning model, and determines a deviation in behavior of the machine learning model by performing statistical analysis on each machine learning model variable to identify statistical differences between machine learning model variable data captured in a given time window and data captured in a previous time window at the same time of a prior day, prior week, etc. If statistical differences exist, the method performs anomaly detection to determine whether the statistical differences are an anomaly. If so, the method determines whether the anomaly causes an impact on business decision output data, and if so, identifying a root cause and generating a notification alert for corrective action.

Abstract: Some aspects of this disclosure include apparatuses and methods for implementing transmission power control. Some aspects relate to an electronic device including a transceiver configured to communicate with a second electronic device and a processor communicatively coupled to the transceiver. The processor is configured to receive an identification information of the second electronic device and receive, from the second electronic device, at least one of a plurality of feedback signals. The plurality of feedback signals includes a first feedback signal generated based on a link quality query from the electronic device and a second feedback signal including an encoded channel status information embedded within an acknowledgment (ACK) frame from the second electronic device. Based on the received identification information and the at least one of the plurality of feedback signals, the processor is configured to adjust transmission power of a signal to be transmitted to the second electronic device.

Abstract: Disclosed herein are compositions and pharmaceutical formulations that comprise a binding moiety conjugated to a modified polynucleic acid molecule and a polymer. Also described herein include methods for treating a disease which utilize a composition or a pharmaceutical formulation comprising a binding moiety conjugated to a polynucleic acid molecule and a polymer.

Abstract: The invention relates to the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck (preferably recurrent squamous cell carcinoma of the head and neck) with a compound which is (3-ethynyl-phenyl)-[7-methoxy-6-(3-morpholin-4-yl-propoxy)-quinazolin-4-yl]-amine (NRC-2694) or a pharmaceutically acceptable salt thereof. The invention also relates to the treatment of head and neck cancer with a compound which is (3-ethynyl-phenyl)-[7-methoxy-6-(3-morpholin-4-yl-propoxy)-quinazolin-4-yl]-amine (NRC-2694) or a pharmaceutically acceptable salt thereof, wherein the treating the head and neck cancer comprises reducing the size of one or more tumours associated with the head and neck cancer.

Abstract: Methods and devices are disclosed for supporting non-emergency community services in a wireless communication network. An end user device may detect activation of an over-the-top (OTT) application, which may be configured to monitor surrounding wireless networks. The end user device may also receive broadcasts identifying a wireless network from an access point that is located nearby, and determine whether the wireless network supports non-emergency community services based on the received broadcasts. In response to determining that the wireless network supports non-emergency community services, the end user device may send a request for details about supported non-emergency community services to the access point, receive a response message from the access point identifying location-specific non-emergency community services offered by the wireless network, and display the offered location-based non-emergency community services.

Abstract: Disclosed herein are system, method, and computer program product embodiments for utilizing non-RAM memory to implement a cloud storage system. An embodiment operates by receiving a request from an on-premises computer system to securely access a cloud drive by receiving an object specific template for an object. Based on the object specific template, an object specific plugin is selected, wherein the object specific plugin is configured to provide a connection to a cloud-based repository to obtain real time data for the object. An instance of the object is generated and communicated to a cloud plugin, wherein the cloud plugin is configured to communicate to a specific cloud drive through an HTTP client and further upload the instance of the object to the specific cloud drive.

Abstract: Disclosed herein are antibody oligonucleotide conjugates and pharmaceutical compositions that induce an alteration in an incorrectly spliced dystrophin mRNA transcript to induce exon 44 skipping. Also described herein include methods for treating muscle dystrophy including Duchenne muscular dystrophy that comprises administering antibody oligonucleotide conjugates or a pharmaceutical composition that induces alteration in an incorrectly spliced dystrophin mRNA transcript to induce exon 44 skipping.

Abstract: Embodiments disclosed herein relate to enabling direct wireless device-to-device communication between sleepy end devices (SEDs) of a mesh (e.g., Thread®) network. A router may forward packets between end devices of the mesh network. However, if the router is not available, SEDs may not be able to communicate with each other using a mesh protocol. Embodiments presented herein enable end devices of the mesh network to communicate directly, without a router. Some embodiments are directed to changing a role of an end device to temporarily act as a router for a particular target end device. The role change may be based on a trigger event and may be temporary until a target action is performed by the target end device. In some embodiments, the end devices continue to operate as SEDs and use coordinated sampled listening techniques to communicate via the mesh protocol.

Abstract: Disclosed herein are molecules and pharmaceutical compositions that induce an insertion, deletion, duplication, or alteration in an incorrectly spliced mRNA transcript to induce exon skipping or exon inclusion. Also described herein include methods for treating a disease or disorder that comprises a molecule or a pharmaceutical composition that induces an insertion, deletion, duplication, or alteration in an incorrectly spliced mRNA transcript to induce exon skipping or exon inclusion.

Abstract: Quantum teleportation is essential for many quantum information technologies, including long-distance quantum networks. Using fiber-coupled devices, including state-of-the-art low-noise superconducting nanowire single-photon detectors and off-the-shelf optics, we achieve conditional quantum teleportation of time-bin qubits at the telecommunication wavelength of 1536.5 nm. We measure teleportation fidelities of ?9% that are consistent with an analytical model of our system, which includes realistic imperfections. To demonstrate the compatibility of our setup with deployed quantum networks, we teleport qubits over 22 km of single-mode fiber while transmitting qubits over an additional 22 km of fiber. Our systems, which are compatible with emerging solid-state quantum devices, provide a realistic foundation for a high-fidelity quantum Internet with practical devices.